908 Devices Inc (NASDAQ:MASS)’s traded shares stood at 12.11 million during the last session, with the company’s beta value hitting 0.96. At the close of trading, the stock’s price was $2.91, to imply an increase of 46.97% or $0.93 in intraday trading. The MASS share’s 52-week high remains $8.50, putting it -192.1% down since that peak but still an impressive 37.8% since price per share fell to its 52-week low of $1.81. The company has a valuation of $101.34M, with an average of 0.4 million shares in intraday trading volume over the past 10 days and average of 335.38K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for 908 Devices Inc (MASS), translating to a mean rating of 1.40. Of 1 analyst(s) looking at the stock, 0 analyst(s) give MASS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.37.
908 Devices Inc (NASDAQ:MASS) trade information
After registering a 46.97% upside in the last session, 908 Devices Inc (MASS) has traded red over the past five days. The 5-day price performance for the stock is 36.62%, and 37.26% over 30 days. With these gigs, the year-to-date price performance is 32.27%. Short interest in 908 Devices Inc (NASDAQ:MASS) saw shorts transact 1.65 million shares and set a 4.42 days time to cover.
908 Devices Inc (MASS) estimates and forecasts
Looking at statistics comparing 908 Devices Inc share performance against respective industry, we note that the company has underperformed competitors. 908 Devices Inc (MASS) shares are -52.84% down over the last 6 months, with its year-to-date growth rate lower than industry average at -76.11% against 14.90%. The rating firms project that company’s revenue will grow 13.87% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 17M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 13.43M.Earnings reports from the last fiscal year show that sales brought in 14.35M and 9.99M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 18.46% before jumping 34.45% in the following quarter.
MASS Dividends
908 Devices Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
908 Devices Inc (NASDAQ:MASS)’s Major holders
908 Devices Inc insiders hold 8.20% of total outstanding shares, with institutional holders owning 69.75% of the shares at 75.98% float percentage. In total, 69.75% institutions holds shares in the company, led by ARK INVESTMENT MANAGEMENT LLC. As of 2024-06-30, the company held over 3.94 million shares (or 12.0377% of shares), all amounting to roughly $20.28 million.
The next major institution holding the largest number of shares is AMERIPRISE FINANCIAL INC with 1.88 million shares, or about 5.7552% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $9.7 million.
We also have ARK ETF Tr-ARK Genomic Revolution ETF and Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I as the top two Mutual Funds with the largest holdings of the 908 Devices Inc (MASS) shares. Going by data provided on Nov 30, 2024 , ARK ETF Tr-ARK Genomic Revolution ETF holds roughly 3.0 shares. This is just over 8.61% of the total shares, with a market valuation of $8.73 million. Data from the same date shows that the other fund manager holds a little less at 1.51, or 4.33% of the shares, all valued at about 4.39 million.
